Krystal Biotech, Inc. KRYS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accounts payable?
- Krystal Biotech, Inc. (KRYS) reported accounts payable of $4.09M in Q1 2026.
- How has Krystal Biotech, Inc.'s accounts payable changed year-over-year?
- Krystal Biotech, Inc.'s accounts payable increased by 53.0% year-over-year, from $2.67M to $4.09M.
- What is the long-term trend for Krystal Biotech, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accounts payable has grown at a 9.0% compound annual growth rate (CAGR), from $2.11M to $3.24M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods or services already received.
- How do you interpret accounts payable?
- An increase can signal effective cash management by delaying payments, while a sudden decrease might indicate aggressive debt reduction or changes in supplier terms.
- How does accounts payable compare across companies?
- Standard across all industries; peers typically manage this based on industry-standard payment terms.